Article Details
Retrieved on: 2020-12-15 15:56:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
On the competition front, <b>Roche</b> and Prothena's similarly acting prasinezumab failed to beat placebo on MDS-UPDRS total score in the phase II ...
Article found on: www.evaluate.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here